rs17849408
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002907.4(RECQL):āc.1899A>Gā(p.Gln633=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0968 in 1,610,128 control chromosomes in the GnomAD database, including 8,730 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.11 ( 1051 hom., cov: 28)
Exomes š: 0.095 ( 7679 hom. )
Consequence
RECQL
NM_002907.4 synonymous
NM_002907.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.379
Genes affected
RECQL (HGNC:9948): (RecQ like helicase) The protein encoded by this gene is a member of the RecQ DNA helicase family. DNA helicases are enzymes involved in various types of DNA repair, including mismatch repair, nucleotide excision repair and direct repair. The encoded protein is involved in the processing of Holliday junctions, the suppression of sister chromatid exchanges, telomere maintenance, and is required for genotoxic stress resistance. Defects in this gene have been associated with several types of cancer. [provided by RefSeq, Jan 2017]
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-21470245-T-C is Benign according to our data. Variant chr12-21470245-T-C is described in ClinVar as [Benign]. Clinvar id is 506624.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.379 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RECQL | NM_002907.4 | c.1899A>G | p.Gln633= | synonymous_variant | 15/15 | ENST00000444129.7 | |
PYROXD1 | NM_024854.5 | c.*1491T>C | 3_prime_UTR_variant | 12/12 | ENST00000240651.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RECQL | ENST00000444129.7 | c.1899A>G | p.Gln633= | synonymous_variant | 15/15 | 2 | NM_002907.4 | P1 | |
RECQL | ENST00000421138.6 | c.1899A>G | p.Gln633= | synonymous_variant | 16/16 | 1 | P1 | ||
PYROXD1 | ENST00000240651.14 | c.*1491T>C | 3_prime_UTR_variant | 12/12 | 1 | NM_024854.5 | P1 | ||
PYROXD1 | ENST00000538582.5 | c.*1491T>C | 3_prime_UTR_variant | 12/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.111 AC: 16751AN: 151206Hom.: 1049 Cov.: 28
GnomAD3 genomes
AF:
AC:
16751
AN:
151206
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.111 AC: 27488AN: 247880Hom.: 1800 AF XY: 0.109 AC XY: 14653AN XY: 134068
GnomAD3 exomes
AF:
AC:
27488
AN:
247880
Hom.:
AF XY:
AC XY:
14653
AN XY:
134068
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0953 AC: 139066AN: 1458804Hom.: 7679 Cov.: 41 AF XY: 0.0952 AC XY: 69089AN XY: 725636
GnomAD4 exome
AF:
AC:
139066
AN:
1458804
Hom.:
Cov.:
41
AF XY:
AC XY:
69089
AN XY:
725636
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.111 AC: 16775AN: 151324Hom.: 1051 Cov.: 28 AF XY: 0.113 AC XY: 8341AN XY: 73930
GnomAD4 genome
AF:
AC:
16775
AN:
151324
Hom.:
Cov.:
28
AF XY:
AC XY:
8341
AN XY:
73930
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
625
AN:
3466
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 15, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at